Esther Marco Selected Research

Esther Marco Research Topics

4	Neoplasms (Cancer) 12/2009 - 07/2007
3	Pancreatic Neoplasms (Pancreatic Cancer) 12/2009 - 10/2007
2	Adenocarcinoma 11/2009 - 10/2009
2	Poisoning 08/2006 - 06/2005
1	COVID-19 01/2022
1	Heart Diseases (Heart Disease) 01/2019
1	Myocardial Ischemia (Ischemic Heart Diseases) 01/2019
1	Asthma (Bronchial Asthma) 11/2010
1	Urinary Bladder Neoplasms (Bladder Cancer) 11/2010
1	Jaundice (Icterus) 12/2009
1	Anorexia 12/2009
1	Fatigue 12/2009
1	Weight Loss (Weight Reduction) 12/2009
1	Fanconi Anemia (Fanconi's Anemia) 05/2008
1	Complementation Group D1 Fanconi Anemia 05/2008
1	Decompression Sickness (Bends) 12/2005

4	Chlorinated HydrocarbonsIBA 12/2009 - 10/2007
3	LipidsIBA 01/2019 - 10/2007
2	Hexachlorobenzene (HCB)IBA 12/2009 - 11/2008
2	Dichlorodiphenyl Dichloroethylene (DDE)IBA 12/2009 - 11/2008
2	erucylphosphocholineIBA 12/2009 - 10/2007
2	DDTIBA 12/2009 - 11/2008
2	Polychlorinated Biphenyls (PCBs)IBA 12/2009 - 11/2008
2	Coffee FDA Link 11/2009 - 10/2007
2	TrabectedinIBA 05/2008 - 08/2006
1	RNA (Ribonucleic Acid)IBA 01/2022
1	LDL CholesterolIBA 01/2019
1	discoidin-binding polysaccharideIBA 11/2010
1	Disinfectants (Biocides)IBA 11/2010
1	Hexachlorocyclohexane (gamma-Hexachlorocyclohexane)FDA LinkGeneric 12/2009
1	beta-hexachlorocyclohexaneIBA 11/2008
1	Persistent Organic PollutantsIBA 11/2008
1	Pharmaceutical PreparationsIBA 05/2008
1	Proteins (Proteins, Gene)FDA Link 05/2008
1	Triglycerides (Triacylglycerol)IBA 10/2007
1	CholesterolIBA 10/2007
1	Biological ProductsIBA 07/2007
1	thiocoralineIBA 07/2007
1	DNA (Deoxyribonucleic Acid)IBA 08/2006
1	Antineoplastic Agents (Antineoplastics)IBA 08/2006
1	OligonucleotidesIBA 12/2005
1	Type I DNA Topoisomerases (Topoisomerase I)IBA 06/2005
1	CamptothecinIBA 06/2005

1	Mechanical Ventilators (Ventilator) 01/2022
1	Secondary Prevention 01/2019